Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

284 projects

  • Pain free vaccination using microneedles

    Development of a microneedle-based delivery system to inject vaccines pain- and stress-free.
  • Development of a better molecular test for colorectal cancer screening

    A better molecular test can reduce the colorectal cancer death rate substantially.
  • Liver fat accumulation and cardiovascular risk: new ways to prevention and treatment

    Accumulation of fat in the liver is an understudied risk factor for cardiovascular disease and topic of current project.
  • Development of next-generation Vero cells to improve vaccine production

    Development of improved Vero cells in disposable bioreactors for enhanced vaccine production
  • The impact of probiotics on brain and behaviour.

    Unravelling probiotic’s gut-brain mechanisms for better understanding of depression and anxiety.
  • Serological markers for monitoring hepatitis B infections and hepatocellular carcinoma

    Serological hepatitis markers integrated into clinical care: towards clinical response assessment and individualized treatment decisions.
  • Pre-emptive stenting of vulnerable non-obstructive coronary lesions

    Pre-emptive, OCT guided stenting of non-obstructive vulnerable coronary lesions in patients after myocardial infarction.